Orrick represented Ipsen in the transaction. Ipsen, a global biopharmaceutical company with a focus on bringing transformative medicines to patients in oncology, rare diseases and neuroscience,...
Ipsen’s $158 Million Sale of Priority Review Voucher
United Therapeutics’ Acquisition of IVIVA
Wilson Sonsini Goodrich & Rosati represented IVIVA in the transaction. United Therapeutics (Nasdaq:UTHR) announced it acquisition of all of the outstanding equity of IVIVA Medical, Inc., a...
Alto Neuroscience’s $35 Million Series B Financing
Wilson Sonsini Goodrich & Rosati advised Alto Neuroscience on the deal. Alto Neuroscience announced the closing of a $35 million Series B financing led by Lightswitch...
Misfits Market’s Acquisition of Imperfect Foods
Wilson Sonsini advised Misfits Market on the deal. Misfits Market, the online grocery platform driven by accessibility, affordability, and sustainability, announced the acquisition of online grocer...
UPSIDE Foods’ $400 Million Series C Funding Round
Wilson Sonsini advised Temasek on the deal. UPSIDE Foods (formerly Memphis Meats), a leading company in the cultivated meat, poultry, and seafood industry, announced the close...
80 Acres Farms’ $160 Million Series B Funding Round
Wilson Sonsini Goodrich & Rosati advised Siemens Financial Services, Inc. on the deal. Acres Farms, an industry-leading vertical farming company, secured $160 million in additional funding...